Concepedia

Leo Dumjahn

LD

Statistics

Publications

1

Citations

67

H-Index

1

Active since

2023

Affiliations

Research Complex at Harwell(Current)

Leo Dumjahn is an author at Research Complex at Harwell specializing in enzyme inhibition, irreversible covalent inhibitors, and antiviral therapeutics.

ORCID

Publications per year

2023–2023

1

Publications

1

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine

Lennart Brewitz, Leo Dumjahn, Yilin Zhao et al. · Journal of Medicinal Chemistry · 2023 · 67 citations · Full text

, , +17

1–1 of 1